Skip to main content
Skip to main content
prescriva
Weight Loss Program

See What Science-Backed Weight Management Could Look Like for You

GLP-1 receptor agonist medications, prescribed by licensed providers and shipped to your door. Take a 4-minute assessment to see if you may be eligible.

220 lbs
150 lbs350 lbs
~41 lbs
Potential weight loss in 12 months
Range: 33–48 lbs

*Based on published clinical trial averages for GLP-1 class medications. Individual results vary based on adherence, health history, and other factors. Your provider will determine if treatment is appropriate for you.

Check Your Eligibility→Starting at $169/mo
Licensed Providers
HIPAA Compliant
Free Shipping
Confident woman and her friend enjoying an active, healthy lifestyle together
Licensed ProvidersEvery prescription is written by an independently licensed clinician after reviewing your health profile.
HIPAA CompliantYour health information is encrypted and protected under federal HIPAA privacy regulations.
Free ShippingPriority shipping on every order, in discreet packaging. No delivery fees, ever.
Cancel AnytimeNo long-term contracts. Cancel or pause your subscription whenever you choose.

Why Willpower Alone Is Not Enough

If diets and exercise alone worked for everyone, no one would still be struggling. The truth is that hunger is not a character flaw. It is driven by hormones your brain responds to every day. Modern medicine has identified a pathway that may help change that signal.

GLP-1 receptor agonists are a class of medications that mimic glucagon-like peptide-1, a hormone your body produces naturally after eating. This hormone travels to the hypothalamus, the brain region that regulates appetite, and signals that you are full. When present at therapeutic levels, GLP-1 receptor agonists may help reduce hunger and food intake by working with your body's existing satiety pathways.

Beyond appetite, research has explored how GLP-1 receptor agonists may slow gastric emptying, meaning food stays in the stomach longer and you may feel satisfied well after a meal. Studies have also investigated their potential effects on metabolic markers including blood sugar regulation and cardiovascular risk factors.

Published clinical trials studying GLP-1 class medications have reported average weight reductions in the range of 15 to 22 percent of body weight over 12 to 18 months, when combined with lifestyle modifications. Individual results vary significantly based on adherence, starting weight, health history, and other factors. Compounded medications have not been evaluated by the FDA for safety, efficacy, or quality.

Appetite Regulation

GLP-1 receptor agonists work by mimicking a naturally occurring hormone that signals fullness to the hypothalamus. Research suggests this may help naturally reduce hunger and cravings without relying on willpower alone.

Wilding et al., NEJM 2021

Metabolic Support

Studies have explored how GLP-1 receptor agonists may help slow gastric emptying and support healthy blood sugar levels. This dual mechanism has been studied for its potential to reduce energy crashes and between-meal cravings.

Jastreboff et al., NEJM 2022

Cardiovascular Research

The SELECT trial studied semaglutide in adults with overweight or obesity and established cardiovascular disease. The trial reported a 20% reduction in major adverse cardiovascular events versus placebo. This data is for the studied medication, not compounded formulations.

Lincoff et al., NEJM 2023

Published trials have reported average body weight reductions of 15-22% for GLP-1 class medications over 12-18 months. Individual results vary. Compounded medications are not FDA-approved.

References

  1. STEP 1 Trial, 2021. New England Journal of Medicine(PMID 33567185).
  2. SURMOUNT-1 Trial, 2022. New England Journal of Medicine(PMID 35658024).
  3. SELECT Cardiovascular Outcomes Trial, 2023. New England Journal of Medicine(PMID 37952131).
  4. STEP 5 Trial (Long-Term Extension), 2022. Nature Medicine(PMID 35132148).
  5. SURMOUNT-2 Trial, 2023. The Lancet(PMID 37385275).

Choose your treatment

Most Popular
Prescriva branded semaglutide injection vial

Semaglutide Injection

A compounded GLP-1 option for weight management

$169/mo

first month, then $289/mo

  • Weekly injection
  • GLP-1 receptor agonist mechanism
  • Gradual dose escalation
  • Provider consultation included
Check Eligibility →View Full Details
Dual-Action
Prescriva branded tirzepatide injection pen

Tirzepatide Injection

Dual-action GLP-1 + GIP receptor agonist

$269/mo

first month, then $389/mo

  • Weekly injection
  • GLP-1 + GIP dual mechanism
  • Advanced formula
  • Provider consultation included
Check Eligibility →View Full Details

Compounded medications are not FDA-approved. All medications require provider approval. Pricing includes provider consultation, medication, and shipping. Cancel anytime.

See If You May Qualify for GLP-1 Treatment

A licensed provider reviews every assessment. No commitment required to check your eligibility.

Start Your Assessment→Starting at $169/mo

4-minute assessment · No commitment · Cancel anytime

A Healthier Everyday

Woman stretching outdoors at sunrise with a city park in the background

Morning movement

Person preparing a colorful vegetable bowl in a modern kitchen

Fueling your day

Two friends walking along a trail surrounded by trees

Active together

Woman smiling confidently while choosing fresh produce at a farmers market

Choosing well

Person journaling at a sunlit table beside a healthy breakfast

Building habits

Couple cooking dinner together in a bright kitchen, laughing

Celebrating progress

Images are for illustrative purposes only and do not represent actual patients or guaranteed results. Certain images may be generated or enhanced using artificial intelligence technologies.

How It Works

~4 min

Complete Your Assessment

Answer questions about your health history, current medications, and weight management goals. The assessment takes about 4 minutes and is reviewed by a licensed provider.

Within 24 hrs

Provider Review

An independently licensed clinician reviews your health profile and determines whether a compounded GLP-1 medication may be appropriate for your individual needs.

Same day

Personalized Prescription

If clinically appropriate, your provider prescribes a compounded medication with a personalized dosing schedule. You choose between injection or oral options based on provider guidance.

3-5 business days

Delivered to Your Door

Your compounded medication is prepared by a state-licensed pharmacy and shipped in discreet packaging with free priority shipping. Ongoing provider support is included.

Frequently Asked Questions

About Treatment

Compounded semaglutide is prepared by state-licensed compounding pharmacies. It is not the same as, equivalent to, or a substitute for any brand-name medication. Compounded medications have not been evaluated by the FDA for safety, efficacy, or quality. Your independently licensed provider will determine whether a compounded medication is appropriate for your individual needs.
Both are GLP-1 receptor agonists, a class of medications that mimic a natural hormone involved in appetite regulation. Semaglutide targets the GLP-1 receptor. Tirzepatide targets both the GLP-1 and GIP receptors, which is sometimes called a dual-action mechanism. Your provider can discuss which option may be more appropriate based on your health profile and goals.
Injections are typically administered once weekly via a small subcutaneous injection. Oral tablets are taken daily as a sublingual dissolvable tablet that dissolves under the tongue. Both deliver a GLP-1 receptor agonist through different routes of administration. Your provider can help determine which option may be most appropriate for your health profile and preferences.

About the Process

The online health assessment takes about 4 minutes. You will answer questions about your medical history, current medications, and weight management goals. A licensed provider reviews your responses typically within 24 hours. Completing the assessment does not create a doctor-patient relationship or guarantee a prescription.
Your subscription includes the provider consultation, compounded medication, free priority shipping, progress tracking tools, and care team support. Pricing covers everything listed above at everything you need to get started. Multi-month plans are available at reduced rates.
Yes. You can cancel your subscription at any time with no cancellation fees or penalties. If you cancel, your subscription will remain active through the end of your current billing period. You can also pause your subscription if you need a break from treatment.

Safety & Side Effects

The most commonly reported side effects of GLP-1 receptor agonists include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These effects are typically mild to moderate and tend to decrease over the first few weeks of treatment as the body adjusts. Your provider will start you at a lower dose and gradually increase it to help minimize side effects. Report any persistent or severe symptoms to your provider promptly.
GLP-1 medications may not be appropriate for individuals with a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a history of pancreatitis, Type 1 diabetes, or those who are pregnant, planning to become pregnant, or breastfeeding. This is not a comprehensive list of contraindications. Your provider will review your full medical history before making any prescribing decision.
Individual experiences vary significantly. Some patients report reduced appetite within the first few weeks of treatment. Meaningful changes in weight typically develop after the initial dose titration period of 4 to 8 weeks. Results depend on individual factors including starting weight, adherence to the treatment plan, diet, exercise, and overall health. Your provider will monitor your progress and adjust your plan as needed.
GLP-1 receptor agonists are studied as an adjunct to lifestyle modifications, not a replacement for them. Published trials that reported significant weight reductions included diet and exercise components alongside medication. Your provider may recommend a balanced nutrition plan and regular physical activity to support your treatment goals. The combination of medication and lifestyle changes has been studied more extensively than medication alone.

Still have questions?

Related Reading

Learn more from our clinical resource library.

Your Weight Management Journey Starts With a 4-Minute Assessment

Answer a few health questions. A licensed provider reviews your profile and determines if treatment may be right for you. Medication ships free to your door.

Check Your Eligibility→Starting at $169/mo

4-minute assessment · No commitment · Cancel anytime

Important Disclosures

The Prescriva platform is operated by Blue Oak Services LLC dba Prescriva, a management services organization (MSO). Blue Oak Services LLC dba Prescriva does not provide medical services, diagnoses, or prescriptions. All medical treatment, including prescribing decisions, is provided by independently licensed healthcare providers. The prescribing provider retains sole discretion over treatment decisions.

Individual results may vary and are not guaranteed. Results may be affected by individual adherence to the treatment plan, lifestyle factors, and the clinical recommendations of your prescribing provider. The information provided on this website is for educational purposes and does not constitute medical advice.

The medications offered through the Prescriva platform are compounded medications. Compounded medications are not FDA-approved. They are prepared by state-licensed compounding pharmacies. Compounded medications have not been evaluated by the FDA for safety, efficacy, or quality. These products are not the same as, equivalent to, or substitutes for FDA-approved medications.

All compounded medications are prepared by state-licensed compounding pharmacies that operate under applicable state and federal regulations. The compounding pharmacies used by Prescriva are independent entities and are not owned or operated by Blue Oak Services LLC dba Prescriva.

Ozempic® is a registered trademark of Novo Nordisk A/S.

Wegovy® is a registered trademark of Novo Nordisk A/S.

Mounjaro® is a registered trademark of Eli Lilly and Company.

Zepbound® is a registered trademark of Eli Lilly and Company.

Images shown are for illustrative purposes only and may feature models or digitally created content. They do not represent actual patients or guaranteed results.

Testimonials and reviews reflect individual experiences and are not representative of all users. Individual results vary based on starting health, adherence to treatment, and lifestyle factors. No specific outcome is guaranteed. These statements have not been evaluated by the FDA.